Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study

被引:12
作者
Barbaro, G [1 ]
Barbarini, G [1 ]
机构
[1] Univ Roma La Sapienza, Dept Emergency Med, Rome, Italy
关键词
consensus interferon; chronic hepatitis C; hepatitis C virus; genotype; 1; non-responders; relapsers;
D O I
10.1097/00042737-200205000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective To evaluate the long-term efficacy of consensus interferon in the treatment of chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, combination therapy with interferon alpha-2b and ribavirin. Design Open label pilot study. Methods Twenty-four chronic hepatitis C outpatient non-responders to (112 cases), or relapsers after (12 cases), standard combination therapy were treated with consensus interferon (9 mug five times per week) for 36 weeks. The patients were followed up for a further 24 weeks. The primary end-point of the study was the rate of sustained virological response. Results Sustained virological response was observed in 33% of previous non-responders and in 42% of previous relapsers. Improvement of the histological score was documented in 80% of previous non-responders and in all previous relapsers who showed undetectable levels of hepatitis C virus RNA at the end of treatment. Logistic regression analysis showed that sustained virological response was associated with a hepatitis C viral load of 2 x 10(6) copies/ml or less, with an inflammation score of 7 or less and with an estimated duration of disease of 10 years or less. The treatment was well tolerated with an 83% compliance. Conclusions Consensus interferon given at a dose of 9 mug five times per week for 36 weeks may offer a good chance of sustained virological response in a subset of patients who failed to respond to, or relapsed after, standard combination therapy. However, a larger randomized trial is required to assess the efficacy of consensus interferon before its use can be advocated for the treatment of such patients. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 26 条
  • [1] Armitage P., 2001, STAT METHODS MED RES, V4th
  • [2] Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience
    Barbaro, G
    Di Lorenzo, G
    Soldini, M
    Giancaspro, G
    Pellicelli, A
    Grisorio, B
    Barbarini, G
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 448 - 455
  • [3] Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone:: An Italian multicenter, randomized, controlled, clinical study
    Barbaro, G
    Di Lorenzo, G
    Soldini, M
    Giancaspro, G
    Bellomo, G
    Belloni, G
    Grisorio, B
    Annese, M
    Bacca, D
    Francavilla, R
    Rizzo, G
    Barbarini, G
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12) : 2445 - 2451
  • [4] Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy:: A randomized trial
    Barbaro, G
    Di Lorenzo, G
    Belloni, G
    Ferrari, L
    Paiano, A
    Del Poggio, P
    Bacca, D
    Fruttaldo, L
    Mongiò, F
    Francavilla, R
    Scotto, G
    Grisorio, B
    Calleri, G
    Annese, M
    Barelli, A
    Rocchetto, P
    Rizzo, G
    Gualandi, G
    Poltronieri, I
    Barbarini, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 107 (02) : 112 - 118
  • [5] The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon
    Blatt, LM
    Davis, JM
    Klein, SB
    Taylor, MW
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (07) : 489 - 499
  • [6] Carithers Jr RL, 1997, HEPATOLOGY S1, V26, p83S
  • [7] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1493 - 1499
  • [8] Fesce E, 1998, ITAL J GASTROENTEROL, V30, P185
  • [9] Re-treatment of chronic hepatitis C with consensus interferon
    Heathcote, EJL
    Keeffe, EB
    Lee, SS
    Feinman, SV
    Tong, MJ
    Reddy, KR
    Albert, DG
    Witt, K
    Blatt, LM
    [J]. HEPATOLOGY, 1998, 27 (04) : 1136 - 1143
  • [10] Therapy of hepatitis C: Consensus interferon trials
    Keeffe, EB
    Hollinger, FB
    Bailey, R
    Bain, VG
    Bala, K
    Balart, L
    Black, M
    Bonkovsky, H
    Cassidy, W
    Craig, JR
    Donovan, J
    Dusheiko, GM
    Ehrinpreis, M
    Everson, G
    Feinman, S
    Foust, RT
    Fromm, H
    Hauser, S
    Heathcote, EJ
    Hoefs, JC
    Hunter, E
    James, S
    Jensen, DM
    Killenberg, P
    Krawitt, EL
    Lee, S
    Lee, WM
    vanLeeuwen, DJ
    Lesesne, H
    Lieberman, H
    Lissoos, T
    Lumeng, L
    Lyche, K
    McHutchison, JG
    Minuk, G
    Mullen, K
    Payne, KM
    Pimstone, N
    Pockros, PJ
    Poterucha, J
    Reddy, KR
    Rosenblate, H
    Shafritz, D
    Smith, C
    Tong, MJ
    White, H
    Willems, B
    [J]. HEPATOLOGY, 1997, 26 (03) : S101 - S107